John Libbey Eurotext

European Journal of Dermatology

MENU

Low detection rate of human papillomavirus in patients with cutaneous squamous cell carcinoma and keratoacanthoma Volume 32, issue 5, September-October 2022

Figures

  • Figure 1.
  • Figure 2.

Tables

Authors
1 Department of Dermatology, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
2 Department of Pathology, Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
Reprints: Chungyeul Kim

Background

The role of human papillomavirus (HPV) in keratoacanthoma (KA) remains unclear.

Objectives

To identify possible differences in HPV DNA, detected by next-generation sequencing (NGS), between KAs and cutaneous squamous cell carcinomas (cSCCs), which may suggest different pathogenesis.

Materials & Methods

We extracted DNA from formalin-fixed and paraffin-embedded (FFPE) tissue blocks from samples of 151 patients (105 with cSCCs and 46 with KAs). HPV DNA was detected using the NGS-based Ezplex® kit. HPV detection rates and other clinical characteristics were compared.

Results

HPV was detected in 6.7% (7/105) of cSCC and 10.9% (5/46) of KA samples. Eight alpha-HPV genotypes (16, 57, 81, 31, 33, 45, 53, and 58) were detected, with HPV 16 being the most common. Only one type (57) is commonly classified as cutaneous type, and the rest are all mucosal types. HPV detection rate did not significantly differ between the KA and cSCC groups.

Conclusion

HPV detection was relatively low in KA and cSCC samples. HPV might be related to the pathogenesis of only selected KA and cSCC cases.